Respiratory Clinical Trials

Statistical methods in respiratory trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All respiratory trials

865 results

• Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 59NCT01822496
• Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 123NCT01565538
• Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations: Complete Statistical AnalysisIndependent statistical analysis of Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 76NCT00977470
• Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00970502).Phase 1/2Results postedn = 15NCT00970502
• ESCAPeIndependent statistical analysis of Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01283009).Phase 3Results postedn = 584NCT01283009
• ESTRELLAIndependent statistical analysis of A Study of Belcesiran in Patients With AATLD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04764448).Phase 2Results postedn = 16NCT04764448
• Etirinotecan Pegol (NKTR-102) in NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Etirinotecan Pegol (NKTR-102) in NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01773109).Phase 2Results postedn = 40NCT01773109
• Etoposide in Patients With COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Etoposide in Patients With COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04356690).Phase 2Results postedn = 8NCT04356690
• EVADEComplete statistical analysis of the randomized phase 2/3 EVADE trial of ADG20 for the prevention of COVID-19, including trial design, primary and secondary endpoints, risk differences, hazard ratios, statistical methodology, safety, and…Phase 2/3Results postedn = 2,582NCT04859517
• Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 25NCT00540436
• Evaluating Immune Response to Seasonal FluMist in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Immune Response to Seasonal FluMist in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01673425).Phase NAResults postedn = 5NCT01673425
• Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: primary endpoint results, effect estimate with…Phase 3Results postedn = 311NCT01498679
• Evaluating the Non-Inferiority of Airmod to Capnostream™35: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Non-Inferiority of Airmod to Capnostream™35: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05263791).Phase NAResults postedn = 284NCT05263791
• Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Powered Surgical Stapler in Video-Assisted Thoracoscopic Lung Resection Procedures in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 105NCT02196675
• Evaluation of Aerosol in a Dental Clinic: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Aerosol in a Dental Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04659928).Phase 4Results postedn = 41NCT04659928
• Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00930982).Phase 2Results postedn = 124NCT00930982
• Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 10NCT03175172
• Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 3,130NCT01130883
• Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu: primary endpoint results, effect estimate with…Phase 3Results postedn = 341NCT01448057
• Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 67NCT05882357
• Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 114NCT04673214
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05011513).Phase 2/3Results postedn = 1,440NCT05011513
• Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 68NCT03971539
• Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 11NCT01679301
• Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 365NCT01785186
• Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 452NCT04576442
• Evaluation of the Effect of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid and MSE): Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Effect of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid and MSE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 54NCT05446714
• Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02483416).Phase NAResults postedn = 30NCT02483416
• Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 44NCT01626989
• Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 330NCT05817045
• Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 338NCT02164539
• Evaluations of Alcohol Warning Labels: Complete Statistical AnalysisIndependent statistical analysis of Evaluations of Alcohol Warning Labels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06129487).Phase NAResults postedn = 1,053NCT06129487
• Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 11NCT01024946
• EvKIndependent statistical analysis of Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 801NCT02643381
• Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing: Complete Statistical AnalysisIndependent statistical analysis of Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07074171).Phase NAResults postedn = 384NCT07074171
• Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01122849).Phase 2Results postedn = 61NCT01122849
• Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 5NCT02301377
• Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): primary endpoint…Phase 3Results postedn = 892NCT01970878
• Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation: Complete Statistical AnalysisIndependent statistical analysis of Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04683744).Phase NAResults postedn = 82NCT04683744
• FACTTIndependent statistical analysis of FACTT (NCT00281268), a phase 3 factorial trial evaluating fluid management strategies in acute respiratory distress syndrome.Phase 3NCT00281268
• Fall Epidemic Viral Pediatric Study: Complete Statistical AnalysisIndependent statistical analysis of Fall Epidemic Viral Pediatric Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01192178).Phase 4Results postedn = 339NCT01192178
• FASTIndependent statistical analysis of FAST as a Treatment for Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01611779).Phase 4Results postedn = 5NCT01611779
• Feasibility of At-Home Handheld Spirometry: Complete Statistical AnalysisIndependent statistical analysis of Feasibility of At-Home Handheld Spirometry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03284203).Phase NAResults postedn = 8NCT03284203
• Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided Cryoprobe: Complete Statistical AnalysisIndependent statistical analysis of Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided Cryoprobe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 30NCT05399082
• Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 11NCT03473548
• Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD: Complete Statistical AnalysisIndependent statistical analysis of Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD: primary endpoint results, effect estimate with…Phase 4Results postedn = 60NCT04655170
• Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea: Complete Statistical AnalysisIndependent statistical analysis of Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01832402).Phase 2Results postedn = 35NCT01832402
• Fetal Tracheal Balloon Study in Diaphragmatic Hernia: Complete Statistical AnalysisIndependent statistical analysis of Fetal Tracheal Balloon Study in Diaphragmatic Hernia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966823).Phase 2Results postedn = 3NCT00966823
• First – In – Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism: Complete Statistical AnalysisIndependent statistical analysis of First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism: primary endpoint results, effect…Phase 1Results postedn = 9NCT03927508
• First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: Complete Statistical AnalysisIndependent statistical analysis of First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: primary endpoint results, effect estimate with…Phase 1Results postedn = 26NCT04535167

← All therapeutic areas